Literature DB >> 9124995

Effects of mefloquine on Ca2+ uptake and release by dog brain microsomes.

H S Lee1, M L Go.   

Abstract

The effects of the antimalarial drug, mefloquine, on the uptake and release of Ca2+ by crude microsomes from dog brain were investigated using a spectrophotometric method. Mefloquine inhibited the inositol-1,4,5-phosphate (IP3)-induced Ca2+ release with an IC50 of 42 microM, but was a weaker inhibitor of the uptake of Ca2+ into the vesicles (IC50: 272 microM). These effects of mefloquine are in contrast to its actions on Ca2+ uptake and release by skeletal muscle microsomes, where its predominant effect was seen to be the inhibition of Ca2+ uptake into the vesicles. Mefloquine was found to be more potent than quinine as a specific inhibitor of Ca2+ release from IP3-sensitive stores in dog brain microsomes. The possibility of the drug affecting cellular IP3-linked signal transduction processes should be considered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9124995

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  9 in total

1.  Inhibitory effects of pepstatin A and mefloquine on the growth of Babesia parasites.

Authors:  Tserendorj Munkhjargal; Mahmoud AbouLaila; Mohamad Alaa Terkawi; Thillaiampalam Sivakumar; Madoka Ichikawa; Batdorj Davaasuren; Tserendorj Nyamjargal; Naoaki Yokoyama; Ikuo Igarashi
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

2.  Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes.

Authors:  S J Coker; A J Batey; I D Lightbown; M E Díaz; D A Eisner
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

3.  Episodic see-saw nystagmus in spino-cerebellar ataxia type 2 (SCA-2).

Authors:  Mario-Ubaldo Manto
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

4.  Effect of sample size and P-value filtering techniques on the detection of transcriptional changes induced in rat neuroblastoma (NG108) cells by mefloquine.

Authors:  Geoffrey S Dow
Journal:  Malar J       Date:  2003-02-27       Impact factor: 2.979

5.  Idiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine.

Authors:  Remington L Nevin
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-04-05       Impact factor: 4.077

6.  Epileptogenic potential of mefloquine chemoprophylaxis: a pathogenic hypothesis.

Authors:  Remington L Nevin
Journal:  Malar J       Date:  2009-08-05       Impact factor: 2.979

Review 7.  Inhibitors of connexin and pannexin channels as potential therapeutics.

Authors:  Joost Willebrords; Michaël Maes; Sara Crespo Yanguas; Mathieu Vinken
Journal:  Pharmacol Ther       Date:  2017-07-15       Impact factor: 12.310

8.  The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro.

Authors:  Geoffrey S Dow; Thomas H Hudson; Maryanne Vahey; Michael L Koenig
Journal:  Malar J       Date:  2003-06-12       Impact factor: 2.979

9.  Gap junction blockers: a potential approach to attenuate morphine withdrawal symptoms.

Authors:  Sabah Moradi; Mohammad Charkhpour; Hamed Ghavimi; Rasoul Motahari; Majid Ghaderi; Kambiz Hassanzadeh
Journal:  J Biomed Sci       Date:  2013-10-21       Impact factor: 8.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.